.avif)
Beta-2 Microglobulin Test - Lymphoma Biomarker
A Beta-2 microglobulin (B2M) test measures a small protein whose elevated levels indicate kidney damage, certain blood cancers (like multiple myeloma and lymphoma), immune activation, or transplant rejection. Identifying abnormalities early can prompt timely treatment and monitoring to reduce risk of kidney failure, delayed cancer diagnosis, or complications after transplant.
ESR Test - Lymphoma Biomarker
The ESR (erythrocyte sedimentation rate) test quickly detects inflammation in the body by measuring how fast red blood cells settle, helping identify infections, autoimmune conditions and other inflammatory disorders. Catching inflammation early can lead to faster treatment and reduce the risk of complications from untreated infections, arthritis flares, temporal arteritis and similar conditions.
.svg)
